Jeffrey Rona

Chief Financial Officer

Mr. Rona is a seasoned executive in the healthcare and biotech industry, with over 20 years of experience in originating, structuring and executing corporate transactions and financings. Prior to joining Great Basin, he was chief business officer of GlobeImmune, a private biopharmaceutical company developing treatments for cancer and infectious diseases. He was vice president of Corporate Development at Corgentech, Inc., following its merger with AlgoRx Pharmaceuticals. Mr. Rona helped execute the transaction in his role as CFO of AlgoRx prior to the merger. Mr. Rona also served in the investment banking department of UBS Warburg, and as director of finance and corporate development at Agenus, where he was instrumental in its IPO. He started his career at Coopers & Lybrand. Mr. Rona has a B.S. in Accounting from Case Western Reserve University.